Healthcare Sector

BMY

Market Tracker

$46.35
+0.15
(+0.32%)
8:00 pm
Next Earnings: (est.) 07/27/23 12:00 am
  • BMY (Selected)

    Bristol-Myers Squibb Company

BMY Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

BMY Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

BMY Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

BMY Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

BMY Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

BMY Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
12/19/2025 PUT $45.00 5,102 +1,311 +34.58%
10/24/2025 CALL $45.00 1,565 +1,269 +428.72%
09/19/2025 CALL $48.00 7,603 +613 +8.77%
10/24/2025 CALL $50.00 527 +483 +1,097.73%
09/19/2025 CALL $49.50 2,810 +479 +20.55%
09/19/2025 CALL $48.50 3,127 +383 +13.96%
12/17/2027 CALL $45.00 334 -124 -27.07%
09/19/2025 PUT $52.50 497 -137 -21.61%
01/16/2026 CALL $52.50 5,069 -153 -2.93%
09/19/2025 CALL $55.00 5,941 -229 -3.71%
09/19/2025 CALL $45.00 1,491 -249 -14.31%
09/19/2025 CALL $47.50 2,332 -875 -27.28%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

BMY Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.07% 64.63M 4.03B
Vanguard 500 Index Fund 2.34% 49.15M 3.06B
Fidelity 500 Index Fund 1.11% 23.31M 1.45B
SPDR S&P 500 ETF Trust 1.09% 23.02M 1.43B
iShares Core S&P 500 ETF 0.90% 18.98M 1.18B
Vanguard Index-Value Index Fund 0.87% 18.37M 1.14B
JP Morgan Equity Income Fund 0.82% 17.35M 1.08B
Select Sector SPDR Fund-Health Care 0.82% 17.27M 1.08B
American Mutual Fund Inc 0.78% 16.49M 1.03B
Vanguard Institutional Index Fund-Institutional Index Fund 0.71% 14.9M 927.91M

BMY News

  • Bipolar Disorder Treatment Pipeline Shows Strong Momentum as 20+ Pharma Companies in the Race | DelveInsight

    09/11 01:00 pm

    GlobeNewswire Inc.

    Read more
  • A Landmark Pivotal Study Applying Precision Medicine to Psychiatry with Denovo’s DB104 (liafensine) for Treatment-Resistant Depression Published in JAMA Psychiatry

    09/11 07:00 am

    GlobeNewswire Inc.

    Read more
  • The Best Ultra-High-Yield Dividend Stock to Invest $1,000 in Right Now

    09/09 06:05 am

    The Motley Fool

    Read more
  • BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

    09/08 02:01 pm

    Benzinga

    Read more
  • Erste Zwischenergebnisse aus BioNTechs und BMS‘ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig (BNT327/BMS986545) zeigen ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem kleinzelligem Lungenkrebs

    09/08 11:00 am

    GlobeNewswire Inc.

    Read more
  • First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

    09/08 11:00 am

    GlobeNewswire Inc.

    Read more
  • Is Pfizer a Millionaire Maker?

    09/07 09:30 am

    The Motley Fool

    Read more
  • Multiple Myeloma Market Size Projected USD 49.89 Billion by 2034

    09/03 11:00 am

    GlobeNewswire Inc.

    Read more
  • Stomach Cancer Treatment Market Review 2020-2024 and Forecast 2025-2030 - Novel Therapies, Increasing Demand for Affordable Treatments, and Favorable Reimbursement Scenario Position the Market for Strong Growth

    09/03 04:49 am

    GlobeNewswire Inc.

    Read more
  • PureTech Health Cash Runway Extended

    09/02 04:19 pm

    The Motley Fool

    Read more
  • Beating The September Curse–These 10 Stocks Shine While The S&P 500 Stumbles

    09/02 10:15 am

    Benzinga

    Read more
  • Healthcare Is Sickly but These Dividend Yields up to 7% May Still Have a Pulse

    08/29 05:14 am

    Investing.com

    Read more
  • Hodgkin’s Lymphoma Market Set to Reach New Heights by 2034 with Innovative Therapies and Clinical Successes | DelveInsight

    08/28 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Scenic Enters License and Research Agreement with Alnylam

    08/26 05:00 am

    GlobeNewswire Inc.

    Read more
  • Anal Cancer Market Size to Reach USD 2.08 Billion by 2032, Fueled by Rising HPV-Linked Cases and Advancements in Targeted Therapies – SNS Insider

    08/22 10:00 am

    GlobeNewswire Inc.

    Read more
  • Questex’s Fierce Pharma Week Announces Star-Studded Lineup with Jamie-Lynn Sigler, James Van Der Beek, Selma Blair, Kelly Killoran Bensimon and John Duffield to Provide Powerful Stories of Resilience and Healing

    08/20 10:00 am

    GlobeNewswire Inc.

    Read more
  • PD-(L)1 Inhibitors Market Set to Surge During the Forecast Period (2025–2034) as Immuno-Oncology Therapies Gain Momentum | DelveInsight

    08/18 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Want Over $2,100 in Annual Dividends? Invest $12,000 Into Each of These 3 High-Yielding Stocks

    08/13 06:26 am

    The Motley Fool

    Read more
  • CytomX (CTMX) Q2 Revenue Drops 26%

    08/07 06:29 pm

    The Motley Fool

    Read more
  • PRME Revenue Misses by 73%

    08/07 12:27 pm

    The Motley Fool

    Read more
  • Global Myeloproliferative Disorder Treatment Market is Expected to Showcase an Incremental Growth at a CAGR of ~5% by 2032 | DelveInsight

    08/06 01:00 pm

    GlobeNewswire Inc.

    Read more
  • BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

    08/04 10:32 am

    Benzinga

    Read more
  • Altanine Names Charles J. Andres, Ph.D., J.D., as CEO to Lead Clinical and Strategic Expansion

    07/29 10:00 am

    GlobeNewswire Inc.

    Read more
  • Oncology Drugs Market Insights, Competitive Landscape, and Forecast Report 2025-2032 | Immunotherapy Leads Growth in Oncology Market Due to Better Precision and Fewer Side Effects

    07/25 10:50 am

    GlobeNewswire Inc.

    Read more
  • Rheumatologists Eye AbbVie’s Rinvoq, Roche/Genentech’s Gazyva, and Bristol Myers Squibb’s Sotyktu as Front-Runners to Address Persistent Gaps in Systemic Lupus Erythematosus Care, Spherix Global Insights Reports

    07/23 12:51 pm

    GlobeNewswire Inc.

    Read more
  • Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight

    07/22 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers' Drug Flunks Blood Cancer-Associated Anemia Trial

    07/18 01:54 pm

    Benzinga

    Read more
  • As Excitement Builds for HR Tech 2025, HR Executive Reveals Finalists of HR Icons Awards

    07/16 07:00 am

    GlobeNewswire Inc.

    Read more
  • 3 Reasons the Schwab U.S. Dividend Equity ETF Is an Attractive Investment for Retirees

    07/16 04:25 am

    The Motley Fool

    Read more
  • FDA Eases Rules For Bristol Myers' Cell Therapies For Blood Cancers

    06/27 11:34 am

    Benzinga

    Read more
  • 2 Beaten-Down Stocks to Avoid

    06/27 08:15 am

    The Motley Fool

    Read more
  • Multiple Sclerosis Clinical Trial Pipeline Shows Potential with Active Contributions from 60+ Key Companies | DelveInsight

    06/24 01:00 pm

    GlobeNewswire Inc.

    Read more
  • ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen

    06/21 06:20 am

    GlobeNewswire Inc.

    Read more
  • ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients

    06/21 06:20 am

    GlobeNewswire Inc.

    Read more
  • Editas Medicine Is Great. Here's Why You Shouldn't Buy It.

    06/17 10:07 am

    The Motley Fool

    Read more
  • 2 Beaten-Down Dividend Stocks to Buy Right Now

    06/16 04:25 am

    The Motley Fool

    Read more
  • Philochem AG Announces the Licensing of Worldwide Rights to OncoACP3, a novel Radiopharmaceutical Therapeutic and Diagnostic Agent targeting Prostate Cancer, to RayzeBio, a Bristol-Myers Squibb Company, for a potential value of up to $1.35bn plus royalties

    06/10 05:55 pm

    GlobeNewswire Inc.

    Read more
  • Rheumatoid Arthritis Global Market Research Report 2025-2035: TNF Inhibitors, IL-6 Inhibitors, and JAK Inhibitors at the Forefront of Developing Biologic Therapies

    06/10 04:53 am

    GlobeNewswire Inc.

    Read more
  • Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight

    06/05 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Epigenetics Market Anticipated to Achieve 11.8% CAGR

    06/03 01:31 pm

    GlobeNewswire Inc.

    Read more
  • Bristol Myers Inks $11 Billion Licensing Pact With BioNTech For Bispecific Cancer Drug

    06/02 10:14 am

    Benzinga

    Read more
  • Bispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight

    05/29 01:16 pm

    GlobeNewswire Inc.

    Read more
  • Rapid Micro Biosystems Announces Appointment of Dr. Dafni Bika to Board of Directors

    05/27 09:00 am

    GlobeNewswire Inc.

    Read more
  • GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases

    05/27 07:00 am

    GlobeNewswire Inc.

    Read more
  • Tubulis Achieves Key Milestone in BMS Strategic License Agreement as First Collaboration Tubutecan ADC Enters the Clinic

    05/20 05:00 am

    GlobeNewswire Inc.

    Read more
  • Blood Cancer Treatment Market Sees Accelerated Growth Across the 7MM Amid Rising Incidence and Breakthroughs | DelveInsight

    05/12 01:00 pm

    GlobeNewswire Inc.

    Read more
  • U.S. Small Business Association Awards Renaissance Global Services Two Prestigious Honors

    05/09 07:00 am

    GlobeNewswire Inc.

    Read more
  • FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight

    05/06 03:21 pm

    Benzinga

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: